This year's event consists of 12 conference programs within 4 streams and is focused on the current trends and science in antibody engineering and development. The conferences include presentations, interactive panels, technology talks, and numerous networking opportunities.
-- DISCOVERY STREAM
Phage & Yeast Display (May 9-10)
Engineering Antibodies (May 11-12)
Antibody Optimization (May 12-13)
-- EXPRESSION STREAM
Difficult to Express Proteins (May 9-10)
Optimizing Protein Expression (May 11-12)
Purifying Antibodies (May 12-13)
-- ANALYTICAL STREAM
Characterization of Biotherapeutics (May 9-10)
Protein Aggregation and Stability in Biopharmaceutical Products (May 11-12)
Understanding and Overcoming Immunogenicity of Protein Therapeutics (May 12-13)
-- ANTIBODIES STREAM
Antibodies for Cancer Therapy: Exploiting Successful Strategies (May 9-10)
Resurgence of Bispecific Antibodies: The Future of Antibody Development (May 11-12)
Antibody Drug Conjugates (May 12-13)
Join over 1200 of your colleagues at this must-attend event. CHI is offering reduced conference registrations to those that register by April 8, 2011.
For additional information and to register, visit http://www.PEGSummit.com or call 781-972-5400.
Writers and editors are invited to attend. To request a press pass, contact Tracey Fielding at firstname.lastname@example.org.
About Cambridge Healthtech Institute (http://www.chicorporate.com)
Cambridge Healthtech Institute (CHI) is the preeminent life science network for leading researchers and business experts from top pharmaceutical, biotech and academic organizations. CHI’s portfolio of products includes Cambridge Healthtech Institute Conferences, Insight Pharma Reports, Barnett International, Cambridge Marketing Consultants, Cambridge Meeting Planners and Cambridge Healthtech’s Media Group, which includes numerous e-newsletters as well as Bio-IT World magazine.
Founded in 1992, Cambridge Healthtech Institute strives to develop quality information sources that provide valuable new insights and competing points of view while offering balanced coverage of the latest developments. Basic research related to commercial implications is covered, with heavy emphasis placed on end-user insights into new products and technology as well as coverage on the strategy behind the business.
Cambridge Healthtech Institute